Author:
Uslaner Jason M.,Eddins Donnie,Puri Vanita,Cannon Christopher E.,Sutcliffe Jane,Chew Chan Sing,Pearson Michelle,Vivian Jeffrey A.,Chang Ronald K.,Ray William J.,Kuduk Scott D.,Wittmann Marion
Publisher
Springer Science and Business Media LLC
Reference69 articles.
1. Anagnostaras SG, Murphy GG, Hamilton SE, Mitchell SL, Rahnama NP, Nathanson NM, Silva AJ (2003) Selective cognitive dysfunction in acetylcholine M1 muscarinic receptor mutant mice. Nat Neurosci 6:51–58
2. Baker SJ, Chin CL, Basso AM, Fox GB, Marek GJ, Day M (2011) Xanomeline modulation of the BOLD signal in awake rats: development of phMRI as a translatable pharmacodynamic biomarker for central activity and dose selection. J Pharmacol Exp Ther. 341:263–273
3. Bartolomeo AC, Morris H, Buccafusco JJ, Kille N, Rosenzweig-Lipson S, Husbands MG, Sabb AL, Abou-Gharbia M, Moyer JA, Boast CA (2000) The preclinical pharmacological profile of WAY-132983, a potent M1 preferring agonist. J Pharmacol Exp Ther 292:584–596
4. Bartus RT, Dean RL 3rd, Beer B, Lippa AS (1982) The cholinergic hypothesis of geriatric memory dysfunction. Science 217:408–414
5. Beguin P, Beggah A, Cotecchia S, Geering K (1996) Adrenergic, dopaminergic, and muscarinic receptor stimulation leads to PKA phosphorylation of Na-K-ATPase. Am J Physiol 270:C131–C137
Cited by
65 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献